Tobramycin administered by the TOBI® Podhaler® for persons with cystic fibrosis: a review
Donald R VanDevanter1, David E Geller21Department of Pediatrics, Case Western Reserve University School of Medicine, Cleveland, OH, 2Nemours Children’s Clinic, Orlando, FL, USAAbstract: From its introduction, the antibiotic tobramycin has been an important tool in the management of per...
Main Authors: | VanDevanter DR, Geller DE |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2011-09-01
|
Series: | Medical Devices : Evidence and Research |
Online Access: | http://www.dovepress.com/tobramycin-administered-by-the-tobireg-podhalerreg-for-persons-with-cy-a8320 |
Similar Items
-
Asthma patients prefer Respimat® Soft Mist™ Inhaler to Turbuhaler®
by: Rick Hodder, et al.
Published: (2009-05-01) -
Developments in administration of growth hormone treatment: focus on Norditropin® Flexpro®
by: Kevin CJ Yuen, et al.
Published: (2011-03-01) -
Comparison of ultra-widefield fluorescein angiography with the Heidelberg Spectralis® noncontact ultra-widefield module versus the Optos® Optomap®
by: Witmer MT, et al.
Published: (2013-02-01) -
Comparison of outcomes of conventional WaveLight® Allegretto Wave® and Technolas® excimer lasers in myopic laser in situ keratomileusis
by: Han DC, et al.
Published: (2012-07-01) -
An evaluation of the accuracy of the ORange® (Gen II) by comparing it to the IOLMaster® in the prediction of postoperative refraction
by: Chen M
Published: (2012-03-01)